东地中海地区的先进心力衰竭疗法:当前状况,挑战和未来方向
Feras Bader1, Yosef Manla1, Hussam Ghalib1
1Department of Cardiology, Heart, Vascular and Thoracic Institute, Cleveland Clinic Abu Dhabi, Al Maryah Island, PO Box 112412, Abu Dhabi, United Arab Emirates.
Current problems in cardiology
|April 10, 2024
概括
东地中海地区 (EMR) 的心力衰竭 (HF) 正在增加,尽管全球的下降. 如心脏移植 (HT) 和机械循环支持 (MCS) 等高级心力衰竭 (AHF) 治疗正在增长,但不足以应对日益增长的负担.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 医学研究 医学研究
背景情况:
- 全球心力衰竭 (HF) 患病率在1990-2019年期间有所下降,但东地中海地区 (EMR) 的患病率呈上升趋势.
- 2019年,EMR的120多万个人患有中度至重度的HF,突出显著的区域负担.
研究的目的:
- 分析EMR中高级心力衰竭 (AHF) 疗法的当前状态和挑战.
- 确定障碍,并提出改善该地区AHF护理的战略.
主要方法:
- 对EMR中已发表的关于高级心力衰竭 (AHF) 治疗的数据的审查,包括心脏移植 (HT) 和机械循环支持 (MCS).
- 对EMR和西方国家的LVAD植入患者人口统计和临床表现的比较分析.
主要成果:
- 在EMR中,心脏移植 (HT) 的数量从2000年的9个增加到2019年的179个,但仍然不足.
- 在EMR中,左心室辅助装置 (LVAD) 数据很少;与西方患者相比,患者年轻,患有严重心脏性休克.
- 缺少多学科计划,高治疗费用,有限的MCS接入,器官短缺和公众意识低,阻碍了AHF的护理.
结论:
- 该EMR面临着日益增长的晚期心力衰竭 (AHF) 负担,超过目前的治疗能力.
- 涉及所有利益关方的多方面的策略至关重要,以应对在EMR中的AHF管理和治疗利用方面的挑战.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Heart Failure Drugs: Inotropic Agents
577
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
577
Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K


